BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 35717510)

  • 1. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.
    Ramsoomair CK; Ceccarelli M; Heiss JD; Shah AH
    J Transl Med; 2023 Dec; 21(1):893. PubMed ID: 38071304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells.
    Cifola I; Fratini F; Cardinali B; Palmieri V; Gatti G; Selmi T; Donzelli S; Sacconi A; Cesarini V; Marei HE; Papi M; Blandino G; Cenciarelli C; Falcone G; D'Agnano I
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.
    Yu J; Lai M; Zhou Z; Zhou J; Hu Q; Li J; Li H; Chen L; Wen L; Zhou M; Cai L
    J Neuroimmunol; 2023 Mar; 376():578034. PubMed ID: 36791582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme.
    Kumari S; Gupta R; Ambasta RK; Kumar P
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188999. PubMed ID: 37858622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA modification patterns based on major RNA modifications define tumor microenvironment characteristics in glioblastoma.
    Li G; Zhu Y; Gu J; Zhang T; Wang F; Huang K; Gu C; Xu K; Zhan R; Shen J
    Sci Rep; 2022 Jun; 12(1):10278. PubMed ID: 35717510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the m
    Yuan F; Cai X; Cong Z; Wang Y; Geng Y; Aili Y; Du C; Zhu J; Yang J; Tang C; Zhang A; Zhao S; Ma C
    Front Immunol; 2022; 13():798583. PubMed ID: 35558067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of main RNA modifications in cancer: N
    Xue C; Chu Q; Zheng Q; Jiang S; Bao Z; Su Y; Lu J; Li L
    Signal Transduct Target Ther; 2022 Apr; 7(1):142. PubMed ID: 35484099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
    Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma.
    Pan Y; Xiao K; Li Y; Li Y; Liu Q
    Front Oncol; 2021; 11():632934. PubMed ID: 33718217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-Cancer Molecular Characterization of m
    Zhu J; Xiao J; Wang M; Hu D
    Front Oncol; 2020; 10():618374. PubMed ID: 33585244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.